CHARTWELL INVESTMENT PARTNERS/PA - NPS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 184 filers reported holding NPS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS/PA ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$7,938,000
-40.9%
265,235
-40.0%
0.16%
-41.5%
Q4 2013$13,423,000
+29.7%
442,130
+35.9%
0.28%
+17.5%
Q3 2013$10,350,000
+55.9%
325,355
-26.0%
0.23%
+38.5%
Q2 2013$6,640,000–439,430–0.17%–
 Download
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q3 2013.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders